| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.62B | -7.5% |
| Cost of Revenue | $6.69B | -5.8% |
| R&D Expense | $27.0M | -35.7% |
| SG&A Expense | $1.06B | -22.6% |
| Operating Income | $2.51B | -3.3% |
| Interest Expense | $816.5M | +8.4% |
| Pre-tax Income | $1.94B | -16.1% |
| Income Tax | $489.9M | -13.3% |
| Net Income | $1.45B | -17.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $419.1M | +12.2% |
| Short-term Investments | $397K | +0.0% |
| Accounts Receivable | $592.4M | -4.4% |
| Inventory | $183.2M | -31.6% |
| Current Assets | $1.48B | -20.1% |
| Total Assets | $7.89B | -29.1% |
| Current Liabilities | $3.23B | -32.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.50B | -1.8% |
| Capital Expenditures | $88.8M | -33.1% |
| Investing Cash Flow | -$1.64B | -516.1% |
| Financing Cash Flow | $341.5M | +122.6% |
| Free Cash Flow | $1.41B | +1.2% |
| Long-term Debt |
| $11.40B |
| +16.9% |
| Total Liabilities | $15.10B | +0.1% |
| Stockholders' Equity | -$7.21B | -82.6% |